Indolinone based phosphoinositide-dependent kinase-1 (PDK1) inhibitors. Part 1: Design, synthesis and biological activity.
Islam, I., Bryant, J., Chou, Y.L., Kochanny, M.J., Lee, W., Phillips, G.B., Yu, H., Adler, M., Whitlow, M., Ho, E., Lentz, D., Polokoff, M.A., Subramanyam, B., Wu, J.M., Zhu, D., Feldman, R.I., Arnaiz, D.O.(2007) Bioorg Med Chem Lett 17: 3814-3818
- PubMed: 17531483 Search on PubMed
- DOI: https://doi.org/10.1016/j.bmcl.2007.04.071
- Primary Citation Related Structures: 
2PE0, 2PE1 - PubMed Abstract: 
HTS screening identified 1 with micromolar inhibitory activity against PDK1. Optimization of 1 afforded 4i (BX-517) which has single-digit nanomolar activity against PDK1 and excellent selectivity against PKA.
- Berlex Biosciences, 2600 Hilltop Dr. Richmond, CA 94804, USA.
Organizational Affiliation: 
















